Dating and hippa
All private placement securities will be restricted from trading for a period of four months from closing. Michael Murphy CEO of Alternate Health commented, “ We are pleased to have attracted investors with strategic relationships in the cannabis industry who can play a significant role in raising future capital and making potential customer introductions.” Murphy also noted, “the proceeds of the private placement will be used for enhanced marketing of our Cana Pass software and our Zi app payment engine as well as for general working capital purposes.” For more information about Alternate Health, visit (CSE: AHG, OTCQB: AHGIF) Alternate Health has established multiple arms-length operations within the medical cannabis industry, each of which drives consumers, data and strategic opportunities to the company’s other verticals.This sophisticated cross-integration of the company’s enterprises has positioned Alternate Health as one of the only cannabis companies that can deliver consistent revenue and intellectual property without growing, manufacturing or distributing the cannabis plant.Langenbach’s education includes a Master's Degree in Management from the Kellogg School of Management at Northwestern University and a Bachelor's Degree in Business Administration from the University of Wisconsin-Madison.Company Updates and Insider Buying As discussed during a recent shareholder call, Alternate Health will be releasing an update to investors within the next seven to 10 days. Murphy, Chairman and CEO, will provide insight on the Company’s operations and ongoing strategy in a letter to shareholders. (CSE: AHG, OTCQB: AHGIF) Alternate Health has established multiple arms-length operations within the medical cannabis industry, each of which drives consumers, data and strategic opportunities to the company’s other verticals.The Notes are secured by the Company’s pledge of marketable securities held by it.
Langenbach spent 12 years on Wall Street with DLJ, CS-First Boston, and Credit Suisse, raising debt and equity capital, advising on M&A transactions and helping form joint ventures.Through its software solutions, data analytics, and patented delivery systems, Alternate Health’s goal is to be the global authority on scientific and clinical support for cannabis in regulated markets.Alternate Health is well positioned to reinvest internal operating cash flow in its platform over the long term, creating an attractive investment profile for its shareholders.“This is an exciting new addition to the Company’s Board of Directors,” says Dr.Michael Murphy, Chairman and CEO of Alternate Health.